Capital Square 1031, a sponsor of Delaware statutory trust investments, announced that CS1031 Diversified Dialysis Portfolio DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.
Each property in the portfolio is 100 percent leased to Fresenius Medical Care, the leading provider of dialysis services and products, on a long-term, net basis with annual CPI rental increases. Fresenius is listed on both the Frankfurt Stock Exchange and New York Stock Exchange, and reported revenues of approximately $20 billion in 2017.
“Capital Square is pleased to fully subscribe this offering of our largest DST portfolio to-date, which provides investors the opportunity to own an interest in a high quality, diversified medical real estate portfolio 100 percent leased to an investment-grade company,” said Louis Rogers, founder and chief executive officer of Capital Square 1031. “The investment benefits from its need-based use — dialysis is a necessary and recurring medical treatment for more than 2.5 million Fresenius patients worldwide.”
Located in Texas, Tennessee, New York, Michigan and Mississippi, the portfolio includes nine properties ranging in size from 3,000 square feet to 10,600 square feet.
Capital Square 1031 provides a range of services, including due diligence, acquisition, loan sourcing, property management/asset management, and disposition, for high net worth investors, private equity firms, family offices and institutional investors. Since inception, the firm has sponsored 50 DSTs and has completed approximately $815 million in transaction volume.